Discover

CANF
Can-Fite BioPharma Ltd.
4.63
2100 x 4.08
300 x 4.00
bid
ask
+
1.66
55.89%
1200 @ 06:25 AM
3.99 -0.64 (13.76%)
Ytd15.75%
1y-77.74%
3.82
day range
5.98
2.56
52 week range
21.00
Open5.02Prev Close2.97Low3.82High5.98Mkt Cap9.92M
Vol57.03MAvg Vol1.84MEPS-10.75P/EN/AForward P/E-2.00
Beta0.57Short Ratio1.96Inst. Own8.02%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning09-0150-d Avg3.18200-d Avg5.521yr Est14.00

CANF News

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se

Can-Fite Highlights Survival Outcomes In Pancreatic Cancer Patients
benzinga.com
Can-Fite Highlights Survival Outcomes In Pancreatic Cancer Patients

Can-Fite BioPharma Ltd. (NYSE:CANF) on Wednesday said its Phase 2a study of Namodenoson in advanced

Can-Fite Highlights Survival Outcomes In Pancreatic Cancer Patients
benzinga.com
Can-Fite Highlights Survival Outcomes In Pancreatic Cancer Patients

Can-Fite's Phase 2a Namodenoson study met its safety endpoint and showed durable survival, suppo

Wall Street is Watching These Biotechs
globenewswire.com
Wall Street is Watching These Biotechs

Three emerging biotechnology companies, Can-Fite (NYSE: CANF), NeOnc (NASDAQ: NTHI), and PMGC (NASDA

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's

benzinga.com
Market-Moving News for July 1st

NKE: -9% | Nike shares are trading lower. The company reported Q4 financial results. BE: 12% | Bloom

Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease
globenewswire.com
Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demo

Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced d

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday&

Can-Fite Stock Jumps After Japan Patent Boosts Obesity Drug Case
benzinga.com
Can-Fite Stock Jumps After Japan Patent Boosts Obesity Drug Case

Can-Fite stock rises after Japan patent allowance strengthens Namodenoson’s obesity and metabolic di

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m

benzinga.com
Market-Moving News for June 26th

ON: -14% | ON stock has given up its prior gain. ON Semiconductor shares were trading higher after t

benzinga.com
Can-Fite BioPharma Announces Japan Patent Allowance Covering Namodenoson’s Anti‑Obesity Activity

The allowed Patent strengthens protection in one of the world's largest pharmaceutical markets a

benzinga.com
Can-Fite BioPharma Announces Publication Of Peer-Reviewed Scientific Article Showing Broad Therapeut

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of pr

benzinga.com
Can-Fite Highlights Pancreatic Cancer Drug Progress

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a clinical-stage biotechnology company developing